Antonio de las Morenas, MD
Professor of Pathology and Laboratory Medicine
Education/Training -
- MEDICAL SCHOOL: FACULTAD DE MEDICINA, SEVILLA, SPAIN
- PATHOLOGY TRAINING: BOSTON UNIVERSITY MEDICAL CENTER
- CYTOPATHOLOGY FELLOWSHIP: HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA
Research Interests -
- BREAST CANCER PATHWAYS
- THYROID PATHOLOGY
Recent Publications -
1. Flanagan JN, Pineda P, Knapp PE, de las Morenas A, Lee SL, Braverman LE. Expression of Cytokeratin 19 in the Diagnosis of Thyroid Papillary Carcinoma by Quantitavie Polymerase Chain Reaction. Endocrine Practice 14 (2): 168-174, 2008.
2.Tripathi A, King Ch., de las Morenas A, Perry VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M, Gerry NP, Marc EL, Rosenberg CL. Gene Expression Abnormalities in histologically normal breast epithilium of breast cancer patients. Internation Journal of Cancer. 18187558 (Published online 30 Nov 2007).
3.Mendez JE. Lamorte WW. de las Morenas A. Cerda S. Pistey R. King T. Kavanah M. Hirsch E. Stone MD. Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma. American Journal of Surgery. 192(4): 538-40, 2006 Oct.
4. Larson PS, Ungarelli RA, de las Morenas A, Cupples A, Rowlings K, Palmer J, Rosenberg CL. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium. Cancer 107 (9): 2122-2126, 2006.Ç
5. Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Path. 209 (3): 307-316, 2006 Apr.
Contact Information
- Email - adlm@bu.edu
